Kim Monkhorst
0000-0002-8690-3811
Netherlands Cancer Institute
5 papers found
Refreshing results…
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer
Real-world utilization of biomarker testing for patients with advanced non-small-cell lung cancer in a tertiary referral center and referring hospitals
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
A serum protein classifier identifying patients with advanced non-small cell lung cancer who derive clinical benefit from treatment with immune checkpoint inhibitors
Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice
Missing publications? Search for publications with a matching author name.